Search

30 Apr 2024: In January 2020, there were 6183 people in the UK currently waiting for an organ transplant.

30 Apr 2024: The clients that we work with are developing test agents (potential new drugs) which will hopefully contribute to helping people with various metabolic and cardiovascular diseases where current treatments are not ... The average age of people with NASH

30 Apr 2024: The Asthma and Lung UK estimates that approximately 12.7 million people in the UK have a history of longstanding respiratory illness including lung cancer and pulmonary fibrosis (scarring of the ... This will allow people to learn about novel aspects of

20 Aug 2021: Who or what will benefit from these outputs, and how? Neurodegenerative disease affects millions of people and animals worldwide.

30 Apr 2024: Huntington’s disease is a rare genetic neurodegenerative disorder affecting approximately 2.71 people per 100,000 worldwide.

15 Nov 2023: Concordat signatories are encouraged to develop policies and processes to support the provision of information to the media, and to ensure that key people in their organisations understand why this is ... Openness means providing information that allows

13 Sep 2021: There are around 7.6 million people living with heart and circulatory diseases in the UK.

30 Apr 2024: In the UK in 2016-2018, almost half of deaths from breast cancer (48%) were in people aged 75 and over (Cancer Research UK website). ... people with TNBC.

19 Aug 2021: There are already approximately 50 million people worldwide with dementia, and as the general population ages, this has been predicted to increase to 150 million by 2050.

30 Apr 2024: The burden of disease is substantial, with more than 164 million people in the EU alone suffering from these diseases.

30 Apr 2024: therapies that will directly benefit people. ... People with MS, in particular, will benefit from this research by the potential provision of cheap and safe drugs to promote remyelination and prevent progressive disability.

30 Apr 2024: We will also aim to ensure that people working under this license are subscribed to the 3Rs newsletter from the National Centre for the 3Rs (NC3Rs).

18 Jun 2021: In addition, if we can develop new treatments for cancer, this will improve people's health-span: their length of healthy life. ... Of course, if people live into dependent old age this may increase societal costs later.

13 Sep 2021: Why is it important to undertake this work? Multiple sclerosis (MS) is a lifelong disease that affects the brain and spinal cord of people of all ages. ... This usually happens in people who are 50 and older. The progressive form of the disease is a

30 Apr 2024: All clients that we work with are developing test agents (potential new drugs) which will hopefully contribute to helping people with various diseases where current treatments are not available or need

13 Sep 2021: By studying early signs of the disease and developing preventative treatments for people at risk a real difference could be made to the prevalence of the disease and the suffering caused

13 Sep 2021: Why is it important to undertake this work? In 2018, over 17 million new cases of cancer were diagnosed worldwide, while 9.6 million people died from the disease.

30 Apr 2024: This will allow people to learn about novel aspects of cancer, ageing and new therapies, and will provide the opportunity for a productive exchange of ideas between the public, patients and

30 Apr 2024: These disruptions combine to produce symptoms which are only successfully treated by current therapies in some people but not others.

25 Jan 2022: people have been appointed, and are already making a difference.  Recent initiatives such as PPL teams and the provision of surgery technicians are to be.